US Bancorp’s Ginkgo Bioworks DNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $67.4K | Sell |
5,992
-310
| -5% | -$3.49K | ﹤0.01% | 2635 |
|
|
2025
Q1 | $35.9K | Buy |
6,302
+1,911
| +44% | +$10.9K | ﹤0.01% | 2894 |
|
|
2024
Q4 | $43.1K | Buy |
4,391
+55
| +1% | +$540 | ﹤0.01% | 2809 |
|
|
2024
Q3 | $35.3K | Sell |
4,336
-359
| -8% | -$2.93K | ﹤0.01% | 2897 |
|
|
2024
Q2 | $62.8K | Sell |
4,695
-2,925
| -38% | -$39.1K | ﹤0.01% | 2544 |
|
|
2024
Q1 | $354K | Sell |
7,620
-449
| -6% | -$20.8K | ﹤0.01% | 1704 |
|
|
2023
Q4 | $545K | Buy |
8,069
+3,198
| +66% | +$216K | ﹤0.01% | 1434 |
|
|
2023
Q3 | $353K | Buy |
4,871
+91
| +2% | +$6.59K | ﹤0.01% | 1550 |
|
|
2023
Q2 | $356K | Sell |
4,780
-2,378
| -33% | -$177K | ﹤0.01% | 1561 |
|
|
2023
Q1 | $381K | Buy |
7,158
+11
| +0.2% | +$585 | ﹤0.01% | 1546 |
|
|
2022
Q4 | $483K | Sell |
7,147
-1,810
| -20% | -$122K | ﹤0.01% | 1414 |
|
|
2022
Q3 | $1.12M | Sell |
8,957
-2,372
| -21% | -$296K | ﹤0.01% | 1008 |
|
|
2022
Q2 | $1.08M | Buy |
11,329
+5,093
| +82% | +$485K | ﹤0.01% | 1062 |
|
|
2022
Q1 | $1.01M | Buy |
+6,236
| New | +$1.01M | ﹤0.01% | 1186 |
|
|
2021
Q4 | – | Sell |
-200
| Closed | -$93K | – | 4083 |
|
|
2021
Q3 | $93K | Buy |
+200
| New | +$93K | ﹤0.01% | 2332 |
|